A detailed history of Victory Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Victory Capital Management Inc holds 13,624 shares of RGEN stock, worth $1.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,624
Previous 19,188 29.0%
Holding current value
$1.94 Million
Previous $2.42 Million 16.17%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$119.79 - $167.35 $666,511 - $931,135
-5,564 Reduced 29.0%
13,624 $2.03 Million
Q2 2024

Aug 05, 2024

SELL
$120.0 - $182.95 $639,000 - $974,208
-5,325 Reduced 21.72%
19,188 $2.42 Million
Q1 2024

May 03, 2024

BUY
$170.78 - $208.42 $553,668 - $675,697
3,242 Added 15.24%
24,513 $4.51 Million
Q4 2023

Feb 05, 2024

BUY
$114.17 - $185.35 $211,328 - $343,082
1,851 Added 9.53%
21,271 $3.82 Million
Q3 2023

Nov 06, 2023

BUY
$138.78 - $176.51 $586,761 - $746,284
4,228 Added 27.83%
19,420 $3.09 Million
Q2 2023

Jul 27, 2023

SELL
$138.42 - $180.31 $560,877 - $730,616
-4,052 Reduced 21.06%
15,192 $2.15 Million
Q1 2023

May 02, 2023

SELL
$154.26 - $198.1 $2.95 Million - $3.79 Million
-19,118 Reduced 49.84%
19,244 $3.24 Million
Q4 2022

Feb 10, 2023

BUY
$162.42 - $220.56 $637,011 - $865,036
3,922 Added 11.39%
38,362 $6.5 Million
Q4 2022

Feb 09, 2023

SELL
$162.42 - $220.56 $13.3 Million - $18 Million
-81,693 Reduced 70.34%
34,440 $5.83 Million
Q3 2022

Nov 02, 2022

BUY
$160.42 - $256.21 $13.8 Million - $22.1 Million
86,148 Added 287.3%
116,133 $21.7 Million
Q2 2022

Aug 01, 2022

SELL
$140.68 - $188.02 $236,483 - $316,061
-1,681 Reduced 5.31%
29,985 $4.87 Million
Q1 2022

May 04, 2022

SELL
$161.19 - $257.96 $222,442 - $355,984
-1,380 Reduced 4.18%
31,666 $4.98 Million
Q4 2021

Feb 07, 2022

SELL
$247.59 - $304.47 $355,291 - $436,914
-1,435 Reduced 4.16%
33,046 $8.75 Million
Q3 2021

Nov 02, 2021

BUY
$194.77 - $324.21 $1.91 Million - $3.18 Million
9,808 Added 39.75%
34,481 $9.97 Million
Q2 2021

Aug 03, 2021

SELL
$165.87 - $220.95 $144,804 - $192,889
-873 Reduced 3.42%
24,673 $4.93 Million
Q1 2021

May 04, 2021

SELL
$180.37 - $226.26 $1.28 Million - $1.6 Million
-7,085 Reduced 21.71%
25,546 $4.97 Million
Q4 2020

Feb 01, 2021

SELL
$148.08 - $206.57 $691,681 - $964,888
-4,671 Reduced 12.52%
32,631 $6.25 Million
Q3 2020

Nov 09, 2020

BUY
$122.51 - $158.27 $1.5 Million - $1.94 Million
12,267 Added 49.0%
37,302 $5.5 Million
Q2 2020

Aug 07, 2020

SELL
$94.33 - $140.48 $108,196 - $161,130
-1,147 Reduced 4.38%
25,035 $3.1 Million
Q1 2020

May 04, 2020

SELL
$84.96 - $109.14 $1.08 Million - $1.39 Million
-12,707 Reduced 32.68%
26,182 $2.53 Million
Q4 2019

Feb 06, 2020

BUY
$73.84 - $93.08 $1.01 Million - $1.27 Million
13,654 Added 54.11%
38,889 $3.6 Million
Q4 2019

Feb 04, 2020

SELL
$73.84 - $93.08 $805,003 - $1.01 Million
-10,902 Reduced 30.17%
25,235 $2.53 Million
Q3 2019

Nov 12, 2019

BUY
$76.65 - $95.51 $2.65 Million - $3.3 Million
34,538 Added 2159.97%
36,137 $2.77 Million
Q2 2019

Aug 15, 2019

SELL
$54.2 - $85.95 $150,784 - $239,112
-2,782 Reduced 63.5%
1,599 $137,000
Q1 2019

May 03, 2019

SELL
$49.45 - $62.8 $321,029 - $407,697
-6,492 Reduced 59.71%
4,381 $259,000
Q4 2018

Feb 05, 2019

BUY
$48.26 - $68.88 $20,365 - $29,067
422 Added 4.04%
10,873 $573,000
Q3 2018

Nov 01, 2018

BUY
$46.8 - $58.97 $176,950 - $222,965
3,781 Added 56.69%
10,451 $580,000
Q2 2018

Aug 02, 2018

BUY
$35.26 - $47.04 $32,262 - $43,041
915 Added 15.9%
6,670 $314,000
Q1 2018

May 04, 2018

BUY
$30.92 - $37.27 $49,843 - $60,079
1,612 Added 38.91%
5,755 $208,000
Q4 2017

Feb 01, 2018

BUY
$32.53 - $38.92 $11,645 - $13,933
358 Added 9.46%
4,143 $150,000
Q3 2017

Oct 27, 2017

SELL
$36.98 - $46.06 $7,987 - $9,948
-216 Reduced 5.4%
3,785 $145,000
Q2 2017

Aug 07, 2017

BUY
N/A
4,001
4,001 $166,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.